ZubrodC. G.: Combinations of Drugs in the Treatment of Acute Leukemias, Proc. Roy. Soc. Med.58: 988 (Nov.) 1965.
2.
SartorelliA. C., and BoothB. A.: The Synergistic Antineoplastic Activity of Combinations of Mitomycins with Either 6–Thioguanine or 5–Fluorouracil, Cancer Res.25: 1393 (Oct.) 1965.
3.
LiM. C., WhitmoreW., and GolbeyR.: Effect of Combined Drug Therapy upon Metastatic Choriocarcinoma, Proc. Am. Assoc. Cancer Res.3: 37 (Mar.) 1969
4.
D'AngioG. J.: The Enhanced Response of the Ridgeway Ostrogenic Sarcoma to Roentgen Radiation Combined with Actinomycin D, Cancer Res.25: 1002 (Aug.) 1965.
JohnsonR. E., and BraceK. C.: Radiation Response of Hodgkin's Disease Recurrent after Chemotherapy, Cancer19: 368 (Mar.) 1966.
7.
American Hospital Formulary Service, American Society of Hospital Pharmacists, Washington, D. C.
8.
RosenbaumE. H., CohenR. A., and GlatsteinH. R.: Vaccination of a Patient Receiving Immunosuppressive Therapy for Lymphosarcoma, J. Am. Med. Assoc.198: 737 (Nov. 14) 1966.
9.
HaimS., and AlroyG.: Methotrexate in Psoriasis, Lancet1: 1165 (May 27) 1967.
10.
KrugerH.-U.: [Blood Sugar-Lowering Effect of Cyclophosphamide in Diabetic Patients], Med. Klin.61: 1462 (Sept. 16) 1966. (Ger.)
11.
DixonR. L., HendersonE. W., and RallD. P.: Plasma Protein Binding of Methotrexate and Its Displacement by Various Drugs, Fed. Proc.24: 454, 1965.
12.
DixonR. L.: Effect of Chlordan Pretreatment on the Metabolism and Lethality of Cyclophosphamide, J. Pharm. Sci.57: 1351–54 (Aug.) 1968.
13.
ElkingM. P.Sr., and KabatH. F.: Drug-Induced Modifications of Laboratory Test Values, Am. J. Hosp. Pharm.25: 485 (Sept.) 1968.
